Call Options

13 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 17, 2022

SELL
$9.75 - $14.44 $2.35 Million - $3.48 Million
-240,700 Reduced 56.86%
182,600 $1.98 Million
Q4 2021

Feb 15, 2022

SELL
$13.17 - $20.94 $2.6 Million - $4.14 Million
-197,700 Reduced 31.84%
423,300 $5.96 Million
Q3 2021

Nov 16, 2021

BUY
$9.16 - $19.83 $4.32 Million - $9.35 Million
471,600 Added 315.66%
621,000 $11.9 Million
Q2 2021

Aug 16, 2021

SELL
$7.25 - $10.99 $721,375 - $1.09 Million
-99,500 Reduced 39.98%
149,400 $1.47 Million
Q1 2021

May 18, 2021

BUY
$4.57 - $11.18 $476,651 - $1.17 Million
104,300 Added 72.13%
248,900 $2.45 Million
Q4 2020

Feb 17, 2021

BUY
$3.73 - $5.6 $2,984 - $4,480
800 Added 0.56%
144,600 $643,000
Q3 2020

Nov 17, 2020

SELL
$4.32 - $11.7 $378,432 - $1.02 Million
-87,600 Reduced 37.86%
143,800 $621,000
Q2 2020

Aug 17, 2020

BUY
$2.94 - $9.1 $635,628 - $1.97 Million
216,200 Added 1422.37%
231,400 $2.05 Million
Q3 2018

Nov 14, 2018

BUY
$11.85 - $16.0 $23,700 - $32,000
2,000 Added 15.15%
15,200 $188,000
Q2 2018

Aug 15, 2018

SELL
$15.15 - $20.75 $318,150 - $435,750
-21,000 Reduced 61.4%
13,200 $201,000
Q1 2018

May 15, 2018

SELL
$14.65 - $19.9 $169,940 - $230,839
-11,600 Reduced 25.33%
34,200 $679,000
Q4 2017

Feb 15, 2018

BUY
$17.3 - $24.08 $269,880 - $375,648
15,600 Added 51.66%
45,800 $856,000
Q3 2017

Nov 14, 2017

BUY
$15.2 - $21.5 $459,040 - $649,300
30,200
30,200 $649,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.63B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.